comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 15:40:26 - browse：67555

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Average age of first period drops to 11.9 years, study shows

leisure time

WSS

Lab trade group sues FDA to halt regulation of lab

Trump got a 'target letter.' What is one and what does it mean?

New warning issued for rebooking air travel after delays, cancellations

What will save rural psychiatry services? Higher Medicaid payments

Celebrate National Dole Whip Day for 3 days this week at Disney

The kidney, in all its complexity, is captured in a new atlas

entertainment

comprehensive

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Report: NIH

Peter Hotez and the public health issue of online harassment

First Opinion Podcast: What happens when kids become caregivers?

Novavax promises a turnaround & Lilly roils the obesity market

AI used to predict Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Man who had jail sentence commuted by Trump arrested again

leisure time

Report: NIH

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

First Opinion Podcast: What happens when kids become caregivers?

iTeos Therapeutics debuts first data on TIGIT

Medical experts are missing from AI regulatory conversations

Focused ultrasound for uterine fibroids: an uphill battle

focus

leisure time

focus

explore